The existence of TMPRSS2:ERG in prostate cancer, along with the significant modulation of TMPRSS2 by androgens, has led to the speculation that the male predominance in the COVID-19 pandemic may be partly attributed to TMPRSS2 [38]. This evidence concerns the gene ERG and prostate carcinoma.